Follow Us:

Home  ›  IVDR  ›  IVDR Certification Statement of Work

IVDR Certification Statement of Work

A phase-by-phase Statement of Work (SOW) for IVDR certification under Regulation (EU) 2017/746. See exactly what I3CGlobal delivers, what the manufacturer provides, and how each step leads to notified body submission and your IVDR CE certificate.

The basics

How an IVDR Statement of Work Helps Regulatory Professionals

An IVDR statement of work (SOW) gives regulatory affairs and quality professionals one agreed plan for IVDR certification. It defines who does what, and when, so every technical file deliverable has a clear owner, deadline and approval step.

  • Assign clear ownership of each activity between the consultant and the manufacturer
  • Plan resources and timelines across all 10 phases of the project
  • Track progress on Annex II and III technical documentation, performance evaluation and PMS
  • Prepare evidence in the order a notified body expects, reducing review rounds

IVDR certification itself is how an in vitro diagnostic manufacturer proves conformity with Regulation (EU) 2017/746: classify the device, implement a QMS, compile Annex II and III technical documentation, complete the performance evaluation and, for most classes, pass a notified body assessment before affixing the CE mark.

The SOW outlined below for IVDR certification explains the activities and responsibilities of consultants and CE applicants (manufacturers), along with deliverables, for the on-time completion of technical documentation and submission to a notified body for obtaining CE certification under the European Union In Vitro Diagnostic Medical Devices Regulation (EU IVDR 2017/746) for an in vitro diagnostic device.

This SOW is designed to build awareness for newcomers applying for IVD CE marking. Minor deviations in the steps may be necessary during actual documentation, depending on the device class and intended use.

EU IVDR CE certification process overview by I3CGlobal
10Documented project phases
A–DRisk classes covered
3Columns: activity, I3CGlobal, manufacturer
1Goal: IVDR CE certificate

Official references: Regulation (EU) 2017/746 (EUR-Lex) · Regulation (EU) 2024/1860 · MDCG guidance · NANDO notified bodies

Last reviewed: 1 November 2026

Roadmap

The 10 Phases of IVDR Certification

Each phase builds a part of the technical file required by Annex II and Annex III of the IVDR. Here is the journey at a glance before the detailed Statement of Work.

  1. Legal address and scopeCompany registration, outsourcing locations and QMS status.
  2. Device informationModels, GMDN/EMDN codes, intended use and risk classification.
  3. IVDR requirements and design controlsStandards, GSPR checklist, DoC, ISO 13485 and IEC 62304 design files.
  4. Risk analysis and usabilityRisk management file, benefit-risk analysis and usability report.
  5. Biocompatibility and V&VBiological evaluation, analytical performance and metrological traceability.
  6. Production controlsProcess, sterilization and clean room validation.
  7. Labelling, storage and packagingLabels, IFU, shelf life and packaging/transport validation.
  8. Quality controlSpecifications, COA, batch release and performance testing.
  9. Performance evaluation and PMSPEP and PER, PMS, vigilance and PMPF.
  10. Notified body certificationSubmission, review rounds, onsite audit and IVDR CE certificate.
Statement of Work

IVDR CE Certification Statement of Work: I3CGlobal vs Manufacturer

The table below lists every activity, the scope handled by I3CGlobal and the inputs or approvals expected from the manufacturer, grouped by phase.

Swipe sideways to view all three columns.

ACTIVITYSCOPE OF I3CGLOBALSCOPE OF MANUFACTURER
PHASE 1
Legal Address and ScopeReview and approveLegal address
Company Registration Certificate
Incorporation Certificate
Review and approveCritical outsourcing locations if any
Address Confirmation
QMS Implementation Status
PHASE 2
Device InformationRequest, review, guide and approveInformation on Previous Govt. Approvals if any
Device Models Confirmation
Generic name
GMDN Code & EMDN Codes
Trade Name/Brand Name
Device Variants Confirmation
SKU (Stock keeping unit)
Previous and similar generations of the device
Overview of Identified Similar Devices
Medical Device Rationale
IVDR Codes
Device Description & Specifications
Review and ApprovalIdentifying key functional component
Device Components
Device Accessories
Hardware/firmware/software
Request, review, guide and approveIntended use
Specification
Risk Classification, Rule, and Justification
Request, review, guide and approveSoftware Safety Classification (IEC 62304)
Indications
Principle of Assay Method (or) Principle of operation of the Instrument
Connections to the device
PHASE 3
Confirmation of IVDR requirements and compliance issuesIdentification of regulations
Harmonized Standards
Non-Harmonized Standards
Device-Specific Standards and CLSI Guidelines
Other Applicable regulations if any
GSPR Checklist
Declaration of Conformity
Documentation of additional declarations
Review and Feedback Documentation as per ISO 13485
  • Design and Development Procedure
  • Development Plan
  • Design and development inputs
  • Design and Development outputs.
  • Design Verification
  • Design Validation
  • Design Approvals
  • Formulation/Drawings/Specification
  • Bill of Materials
  • Design and Development Review
Design Controls (Software) in line with IEC 62304Review and Feedback Documentation as per ISO 13485 / IEC 62304
  • Development Plan
  • Requirements Analysis
  • Architectural Design
  • Detailed Design
  • Unit Implementation
  • Unit Verification
  • Integration and Integration Testing
  • System Testing
  • Software Configuration Management
  • Software Risk Management Process
  • The code and code reviews
  • Software validation and release
PHASE 4
Risk Analysis & UsabilityDevelopment of Procedures and Templates and Implementation Guidance and coordination with manufacturer team Support and coordination with consultants in the risk management process.
  • Conduct of Risk Analysis
  • Team support and suggestions
Risk Mitigation
Benefit-Risk Analysis
Risk Management File documentationReview
Usability engineering procedure and templateSupport and suggestions
Guidance, review and approvalUsability engineering report
PHASE 5
Biocompatibility
(It will be applicable based on the type and duration of contact with the human body)
Biological Evaluation procedure and templates
Identification of biocompatibility compliance requirements
Biocompatibility Plan
GuidanceBiocompatibility Test Reports
Product Verification and ValidationRequest, review, guide and approveInformation on the Performance of the device (Analytical Performance)
Request, review, guide and approveMetrological Traceability
Request, review, guide and approveChemical, Physical, and Biological Properties
PHASE 6
Production ControlsRequest, review, guide and approve.Process Flow chart
Critical Process Identification
Critical Process Validation
  • Protocol and reports
Sterilization Validation
  • Validation protocol
  • Validation Report
Request, review, guide and approve. Clean Room Validation
  • Protocols
  • Reports
  • Supporting Evidence
  • Bioburden protocol and Records
PHASE 7
Device LabellingRequest, review, guide and approve. Device information Panel
  • Primary/Secondary Labels
  • Device embossing
Instructions for Use/User Manual /LeafletIFU/User Manual
Device StorageStorage / Storage Temperatures
Lifetime/Shelf life
  • Lifetime
  • Shelf-Life
Packaging Controls (Active, Non-Active Devices) Device Packing
  • Method of packing
  • Packing validation protocol/reports
  • Transport
  • Transport validation protocol and reports
PHASE 8
Quality ControlRequest, review and approve.Specifications of the finished device
Specification of Critical Raw Materials/Components
Quality Plan/Control Plan
Certificate of Analysis (COA)
Batch Release (Batch Manufacturing Record)
Request, review, guide and approve.Performance Testing
Review and approve.Electrical Safety Testing
PHASE 9
Performance Evaluation Development of Quality System Procedure, if not available with the manufacturer
  • I3C may modify or suggest modifications to the manufacturer's existing QSP.
  • Extend necessary support with document numbering based on IVD MDQMS and control of documents
Guidance and drafting of templates
  • Assign Performance evaluator(s) and arrange the CV and DOI
Develop a detailed Performance Evaluation Plan
  • Develop the PEP template and fill it based on the clinical evidence provided by the manufacturer such as IFU or User guide, RMF, or previous PER.
  • Develop a Literature search plan template and add information on literature search strategies.
  • Develop an Appraisal plan template and add information – the criteria for appraisal of all the pertinent
  • Clarify doubts, when necessary.
  • Assign responsibilities.
  • Review and approve PEP, Literature search plan, and Appraisal plan
Performance Evaluation
  • Guides manufacturers on pre-clinical and non-clinical studies.
  • Identifies clinical evidence that can be retrieved from the manufacturer and adds data based on that to the template.
  • Extend necessary support for consultants with pre-clinical data in a systematic way.
  • Provide information on any clinical studies such as Clinical performance studies as ISO 20916 or Post-market studies on the device
  • Develop relevant Literature search and review report template.
  • Perform a systematic and comprehensive literature search from scientific databases based on research questions to meet the requirements of Annex I, GSPR [EU IVDR 2017/746], and SOTA/SOA, and prepare the literature search report for meeting the requirement of safety and performance of the device.
  • Prepare a literature search review report based on the review questions added to the Literature search plan.
  • Develop a Demonstration of Equivalence in PER based on MDCG 2020-5 guidance.
  • Performs Demonstration of equivalence, if applicable
  • Inform about similar device details obtained from pieces of literature (if any)
  • Identification of equivalent device and provide the details for demonstration of equivalence (if claiming the equivalency)
  • Must have sufficient access to equivalent device data on an ongoing basis (if applicable)
  • Develop appraisal of clinical evidence plan template.
  • Appraises and performs qualitative analysis of the clinical data obtained from the literature as well as clinical evidence retrieved from the manufacturer based on corresponding GSPRs and also on the criteria set in the Appraisal plan.
  • Develop PER template.
  • Adds information on the PER template based on the summary of inputs from the clinical evidence provided by the manufacturer and/or the literature or from the Clinical performance study report from step 1 to step 3 meeting the GSPRs.
Post-Market Surveillance and Vigilance Reporting
  • Develops or modify the PMS procedure, if required
  • Analysis based on collected PMS data based on the reactive and proactive sources selected by the manufacturer.
  • Support PMS planning.
  • PMS period confirmation
  • Supports in selecting the sources from our PMS Plan provided by us.
  • Guidance on Vigilance and CAPA if required.
  • Decision on whether a PMPF study needs to be conducted based on the feedback and risk classification.
  • Preparation of PMS report of Class A and B or PSUR if Class C and D
Vigilance Control Procedure as per IVDR Articles 82–87
  • Extend necessary support by following the PMS plan scheduled for the period.
  • Collect PMS data based on the PMS sources chosen.
  • Organize Customer Feedback
  • Organize Sales History and Sales volume data.
  • Organize User Feedback in the drafted and provided.
  • Follow Vigilance and CAPAs if any required.
Review and approve PMS plan, other evidence and PMSR/PSUR
Post Market Performance Follow-up
  • Prepares procedure for PMPF, if required.
  • Prepares PMPF Plan & Evaluation Report templates based on the MDCG guidance.
  • Support in the selection of devices for PMPF.
  • Review the data entered in the PMPF plan to meet the chosen PMPF objective.
  • Guides manufacturers to choose the suitable method as per the characteristics and type of IVD medical devices.
  • Develop a well-defined PMPF study template and PMPF evaluation report template.
  • Verifies the findings and the results based on the PMPF activity chosen by the manufacturer.
Analysis & Conclusion based on the study (by the evaluator) in the PMPF evaluation report.
  • Extend necessary support by following the PMPF plan.
  • Follow the PMPF period selected in line with the PMS.
  • Identify a List of Study Centres
  • Method of PMPF study based on Consultants Inputs
  • Clinical Performance study (If applicable) to be outsourced to a third-party agency.
Review and approve the PMPF plan, other evidence and the PMPF Evaluation Report
PHASE 10
Notified Body Submission, Review, Onsite Audit, and Issue of Certificate or NB Opinion LetterSupport in the Identification of Notified Body
NB Application and Contract Signing
Technical Documentation Submission to NB
Answering initial NB review comments and resubmission of TDFSupport and suggestions
Answering 2nd round NB review comments and resubmission of TDF
Onsite QMS Audit and closing of NCs
Review draft IVDR CE CertificateConfirm contents in the IVDR CE Certificate draft
Accept IVDR CE Certificate (Soft/Hard) or Notified Body Opinion Letter

Want this SOW tailored to your IVD device class and timeline?

Submit your email for a reply message with more information, about how we can help you with IVDR certification in seconds.

Work with I3CGlobal

Achieve IVDR Certification for Your IVD Device

Our IVDR consultants manage the full Statement of Work for Class A through Class D devices, from scope review to notified body certification.

Start your IVDR certification project

Share your device details and get a tailored proposal.

Request a Quote See Pricing
FAQs

IVDR Certification Statement of Work: Frequently Asked Questions

What is IVDR certification?

IVDR certification is the route an in vitro diagnostic manufacturer follows to show conformity with Regulation (EU) 2017/746. It covers device classification, a compliant QMS, technical documentation per Annex II and III, performance evaluation, post-market surveillance and, for most devices, notified body certification before the CE mark is affixed.

What is included in an IVDR statement of work?

An IVDR statement of work lists every activity needed for IVDR certification across 10 phases and states which tasks the consultant delivers and which inputs, data and approvals the manufacturer provides, from scope review and device information through technical documentation, performance evaluation and post-market surveillance to notified body submission and the CE certificate.

Do all IVD devices need a notified body under the IVDR?

No. Non-sterile Class A devices are self-declared by the manufacturer. Class A sterile devices need notified body involvement for sterility aspects, and Class B, C and D devices require a full notified body conformity assessment. See our IVDR classification guide.

What does the manufacturer have to provide during the process?

The manufacturer supplies legal and company records, device information, design and production data, test reports, clinical evidence and post-market data, and reviews and approves the documents I3CGlobal prepares. The Statement of Work table above lists these inputs phase by phase.

What is the role of performance evaluation in IVDR CE certification?

Performance evaluation demonstrates scientific validity, analytical performance and clinical performance of the device. The results are documented in the performance evaluation report (PER) and kept up to date through post-market performance follow-up.

Which post-market reports are required for each class?

Class A and Class B manufacturers prepare a post-market surveillance report (PMSR). Class C and Class D manufacturers prepare a periodic safety update report (PSUR), which is updated at least annually.

Can I3CGlobal support the notified body submission and audit?

Yes. We help identify a suitable notified body, prepare the technical documentation submission, answer review questions across rounds, and support the onsite QMS audit and closure of nonconformities until the IVDR CE certificate is issued.

What are the IVDR transition deadlines for legacy devices?

Under Regulation (EU) 2024/1860, legacy IVDs covered by a Directive certificate or declaration can stay on the market until 31 December 2027 (Class D), 31 December 2028 (Class C) and 31 December 2029 (Class B and Class A sterile), provided the manufacturer had an IVDR QMS by 26 May 2025, applies to a notified body and signs a written agreement by the class-specific dates, and makes no significant changes to the device. Check the European Commission transitional provisions page for any later amendments.

How much does IVDR CE certification cost?

Cost depends on device class, the number of devices and variants, the evidence already available and the notified body fees. See our IVDR CE certification cost page for a breakdown, or request a tailored quote.

How long does IVDR CE certification take?

It depends on the device class, how complete your existing documentation and performance evidence are, and the notified body's workload. Class A non-sterile devices can be self-declared once the technical documentation is ready. Devices that need notified body certification usually take longer, often more than a year, because of application, document review rounds and the QMS audit. I3CGlobal plans your timeline after a gap assessment.